| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |